Compare NBY & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NBY | PNNT |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.2M | 397.7M |
| IPO Year | 2007 | 2007 |
| Metric | NBY | PNNT |
|---|---|---|
| Price | $0.77 | $5.67 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.95 |
| AVG Volume (30 Days) | ★ 2.4M | 634.5K |
| Earning Date | 11-07-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 16.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.47 | ★ 0.50 |
| Revenue | $10,302,000.00 | ★ $122,377,000.00 |
| Revenue This Year | $23.91 | N/A |
| Revenue Next Year | $32.05 | N/A |
| P/E Ratio | $30.13 | ★ $11.33 |
| Revenue Growth | ★ 390.34 | N/A |
| 52 Week Low | $0.46 | $5.57 |
| 52 Week High | $19.95 | $7.53 |
| Indicator | NBY | PNNT |
|---|---|---|
| Relative Strength Index (RSI) | 35.42 | 38.97 |
| Support Level | $0.75 | $5.57 |
| Resistance Level | $2.13 | $5.85 |
| Average True Range (ATR) | 0.58 | 0.11 |
| MACD | -0.61 | -0.02 |
| Stochastic Oscillator | 0.26 | 20.93 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.